Breakthroughs at Blueprint Medicines
Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development engine. Blueprint's drug development strategy was twofold-it focused on creating a single drug compound for multiple disease indications, while at the same time developing drugs to track a disease through its progression. The company's goal was to become a fully integrated biopharmaceutical company that could move from drug discovery to development to marketing. But it was increasingly challenging to prioritize and manage programs, personnel and partnerships.
【書誌情報】
ページ数:17ページ
サイズ:A4
商品番号:HBSP-820001
発行日:2020/6/29
登録日:2020/8/20